NOS2 and obesity disorder: The chronic administration of 1400W, like iNOS deficiency, led to similar anti-hypertrophic, anti-fibrotic, and anti-edematous effects in the TAC model [147], and improved perfusion reserve with reduced oxidative stress in the obesity-induced PH-LHD model [22].